Key transcriptional regulators of the vasoprotective effects of shear stress

R. A. Boon; A. J. G. Horrevoets

doi:10.1055/s-0037-1616937

Hämostaseologie, Table of Contents

Hamostaseologie 2009; 29(01): 39-43
DOI: 10.1055/s-0037-1616937

Original article

Schattauer GmbH

Key transcriptional regulators of the vasoprotective effects of shear stress

R. A. Boon

¹Department of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands

,

A. J. G. Horrevoets

¹Department of Molecular Cell Biology and Immunology, VU University Medical Center, Amsterdam, The Netherlands

› Author Affiliations

Abstract

Summary

Atherosclerotic plaque rupture and subsequent thrombosis is the main cause of sudden coronary death. Remarkably, atherosclerosis only develops in certain predisposed areas of the vasculature. Endothelial cells in these predisposed areas experience low or oscillatory shear stress, which activates the proinflammatory and procoagulant transcription factors activator protein 1 (AP-1) and nuclear factor B (NFB), thus inducing a proinflammatory, procoagulant surface. In contrast, healthy endothelial cells that are exposed to prolonged high laminar shear stress, express antiinflammatory and anticoagulant genes. The key shear stress-induced transcription factors that govern the expression of these genes are Krüppel-like factor 2 (KLF2) and nuclear factor erythroid 2-like 2 (Nrf2). Together KLF2 and Nrf2 govern ~70% of the shear stress-elicited gene sets. Nrf2 potently induces anti-inflammatory/antioxidant enzymes, while KLF2 induces anti-inflammatory and anticoagulant proteins, most specifically endothelial Nitric oxide synthase (eNOS) and thrombomodulin (TM). KLF2 also inhibits proinflammatory and antifibrinolytic genes through inhibition of the proinflammatory transcription factors AP-1 and NFB. The widespread beneficial effects of the key transcription factors KLF2 and Nrf2 on endothelial phenotype, holds the promise that their targeted modulation might lead to a new class of cardiovascular drugs.

Keywords

Shear stress - transcription factor - KLF2 - Nrf2

Full Text

References

References
1 Farb A, Tang AL, Burke AP. et al. Sudden coronary death: Frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. Circulation 1995; 92: 1701-1709.
2 Zarins CK, Giddens DP, Bharadvaj BK. et al. Carotid bifurcation atherosclerosis. Quantitative correlation of plaque localization with flow velocity profiles and wall shear stress. Circ Res 1983; 53: 502-514.
3 Davids N. Finite element methods of studying mechanical factors in blood flow. Neurol Res 1981; 3: 83-105.
4 Tzima E, Irani-Tehrani M, Kiosses WB. et al. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 2005; 437: 426-431.
5 Lan QX, Mercurius KO, Davies PF. Stimulation of transcription factors NFB and AP1 in endothelial cells subjected to shear stress. Biochem Biophys Res Comm 1994; 201: 950-956.
6 Fledderus JO, van Thienen JV, Boon RA. et al. Prolonged shear stress and KLF2 suppress constitutive proinflammatory transcription through inhibition of ATF2. Blood 2007; 109: 4249-4257.
7 Nagel T, Resnick N, Dewey Jr CF, Gimbrone Jr MA. Vascular endothelial cells respond to spatial gradients in fluid shear stress by enhanced activation of transcription factors. Arterioscler Thromb Vasc Biol 1999; 19: 1825-1834.
8 Brand K, Page S, Rogler G. et al. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest 1996; 97: 1715-1722.
9 Resnick N, Gimbrone Jr MA. Hemodynamic forces are complex regulators of endothelial gene expression. FASEB J 1995; 9: 874-882.
10 Gimbrone Jr MA, Topper JN, Nagel T. et al. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann NY Acad Sci 2000; 902: 230-239.
11 Ranjan V, Xiao Z, Diamond SL. Constitutive NOS expression in cultured endothelial cells is elevated by fluid shear stress. Am J Physiol Heart Circ Physiol 1995; 269: H550-H555.
12 Takada Y, Shinkai F, Kondo S. et al. Fluid shear stress increases the expression of thrombomodulin by cultured human endothelial cells. Biochem Biophys Res Commun 1994; 205: 1345-1352.
13 Passerini AG, Polacek DC, Shi C. et al. Coexisting proinflammatory and antioxidative endothelial transcription profiles in a disturbed flow region of the adult porcine aorta. Proc Natl Acad Sci USA 2004; 101: 2482-2487.
14 Dekker RJ, van Soest S, Fontijn RD. et al. Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Kruppel- like factor. Blood 2002; 100: 1689-1698.
15 Chen XL, Varner SE, Rao AS. et al. Laminar flow induction of antioxidant response element-mediated genes in endothelial cells. A novel anti-inflammatory mechanism. J Biol Chem 2003; 278: 703-711.
16 Dai G, Vaughn S, Zhang Y. et al. Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2. Circ Res 2007; 101: 723-733.
17 Dekker RJ, van Thienen JV, Rohlena J. et al. Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes. Am J Pathol 2005; 167: 609-618.
18 Fledderus JO, Boon RA, Volger OL. et al. KLF2 primes the antioxidant transcription factor Nrf2 for activation in endothelial cells. Arterioscler Thromb Vasc Biol 2008; 28: 1339-1346.
19 Nakaso K, Yano H, Fukuhara Y. et al. PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells. FEBS Lett 2003; 546: 181-184.
20 Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 2007; 47: 89-116.
21 Kraft AD, Johnson DA, Johnson JA. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydro - quinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J Neurosci 2004; 24: 1101-1112.
22 Van Thienen JV, Fledderus JO, Dekker RJ. et al. Shear stress sustains atheroprotective endothelial KLF2 expression more potently than statins through mRNA stabilization. Cardiovasc Res 2006; 72: 231-240.
23 Sohn SJ, Li D, Lee LK, Winoto A. Transcriptional regulation of tissue-specific genes by the ERK5 mitogen-activated protein kinase. Mol Cell Biol 2005; 25: 8553-8566.
24 Parmar KM, Larman HB, Dai G. et al. Integration of flow-dependent endothelial phenotypes by Kruppel- like factor 2. J Clin Invest 2005; 116: 49-58.
25 Huddleson JP, Ahmad N, Lingrel JB. Up-regulation of the KLF2 Transcription Factor by Fluid Shear Stress Requires Nucleolin. J Biol Chem 2006; 281: 15121-15128.
26 Huddleson JP, Ahmad N, Srinivasan S, Lingrel JB. Induction of KLF2 by fluid shear stress requires a novel promoter element activated by a phosphatidylinositol 3-kinase-dependent chromatin-remodeling pathway. J Biol Chem 2005; 280: 23371-23379.
27 Kumar A, Lin Z, Senbanerjee S, Jain MK. Tumor necrosis factor alpha-mediated reduction of KLF2 is due to inhibition of MEF2 by NF-{kappa}B and histone deacetylases. Mol Cell Biol 2005; 25: 5893-5903.
28 Parmar KM, Nambudiri V, Dai G. et al. Statins exert endothelial atheroprotective effects via the KLF2 transcription factor. J Biol Chem 2005; 280: 26714-26719.
29 Sen-Banerjee S, Mir S, Lin Z. et al. Kruppel-like factor 2 as a novel mediator of statin effects in endothelial cells. Circulation 2005; 112: 720-726.
30 Chan K, Kan YW. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc Natl Acad Sci USA 1999; 96: 12731-12736.
31 Wakabayashi N, Itoh K, Wakabayashi J. et al. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat Genet 2003; 35: 238-245.
32 Kuo CT, Veselits ML, Barton KP. et al. The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis. Genes Dev 1997; 11: 2996-3006.
33 Wu J, Bohanan CS, Neumann JC, Lingrel JB. KLF2 transcription factor modulates blood vessel maturation through smooth muscle cell migration. J Biol Chem 2008; 283: 3942-3950.
34 Lee JS, Yu Q, Shin JT. et al. Klf2 is an essential regulator of vascular hemodynamic forces in vivo. Dev Cell 2006; 11: 845-857.
35 Wang X, Merritt AJ, Seyfried J. et al. Targeted deletion of mek5 causes early embryonic death and defects in the extracellular signal-regulated kinase 5/myocyte enhancer factor 2 cell survival pathway. Mol Cell Biol 2005; 25: 336-345.
36 Regan CP, Li W, Boucher DM. et al. Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects. Proc Natl Acad Sci USA 2002; 99: 9248-9253.
37 Lin Q, Lu J, Yanagisawa H. et al. Requirement of the MADS-box transcription factor MEF2C for vascular development. Development 1998; 125: 4565-4574.
38 Wang L, Fan C, Topol SE. et al. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 2003; 302: 1578-1581.
39 Atkins GB, Wang Y, Mahabeleshwar GH. et al. Hemizygous deficiency of Kruppel-like factor 2 augments experimental atherosclerosis. Circ Res 2008; 103: 690-693.
40 Lin Z, Kumar A, Senbanerjee S. et al. Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ Res 2005; 96: e48-e57.
41 Senbanerjee S, Lin Z, Atkins GB. et al. KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation. J Exp Med 2004; 199: 1305-1315.
42 Dekker RJ, Boon RA, Rondaij MG. et al. KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium. Blood 2006; 107: 4354-4363.
43 Boon RA, Fledderus JO, Volger OL. et al. KLF2 suppresses TGF-beta signaling in endothelium through induction of Smad7 and inhibition of AP-1. Arterioscler Thromb Vasc Biol 2007; 27: 532-539.
44 Lin Z, Hamik A, Jain R. et al. Kruppel-like factor 2 inhibits protease activated receptor-1 expression and thrombin-mediated endothelial activation. Arterioscler Thromb Vasc Biol 2006; 26: 1185-1189.
45 Hayashi M, Kim SW, Imanaka-Yoshida K. et al. Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure. J Clin Invest 2004; 113: 1138-1148.